Interferon-α production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus

被引:48
作者
Nfon, Charles K. [1 ]
Ferman, Geoffrey S. [1 ]
Toka, Felix N. [1 ]
Gregg, Douglas A. [1 ]
Golde, William T. [1 ]
机构
[1] USDA ARS, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA
关键词
D O I
10.1089/vim.2007.0097
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Viruses have evolved multiple mechanisms to evade the innate immune response, particularly the actions of interferons (IFNs). We have previously reported that exposure of dendritic cells (DCs) to foot-and-mouth disease virus (FMDV) in vitro yields no infection and induces a strong type I IFN (IFN-alpha and IFN-beta) response, indicating that DCs may play a critical role in the innate response to the virus. In vivo, FMDV induces lymphopenia and reduced T-cell proliferative responses to mitogen, viral effects that may contribute to evasion of early immune responses. In this study we analyzed the in vivo effects of FMDV infection on the IFN-alpha response of two populations of dendritic cells. During the acute phase of infection of swine, production of IFN-alpha from monocyte-derived DCs (MoDCs) and skin-derived DCs (skin DCs) is inhibited. This effect occurs concurrently with rising viral titers in the blood; however, these cells are not productively infected. Interestingly, there are no changes in the capability of these DCs to take up particles and process antigens, indicating that antigen-presenting cell function is normal. These data indicate that inhibition of the IFN-alpha response of dendritic cell populations from blood and skin by FMDV enhances viral pathogenesis in infected animals.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 34 条
  • [11] Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle
    Brown, CC
    Piccone, ME
    Mason, PW
    McKenna, TSC
    Grubman, MJ
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (08) : 5638 - 5641
  • [12] Novel viral disease control strategy: Adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease
    Chinsangaram, J
    Moraes, MP
    Koster, M
    Grubman, MJ
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (02) : 1621 - 1625
  • [13] Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase
    Chinsangaram, J
    Koster, M
    Grubman, MJ
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (12) : 5498 - 5503
  • [14] Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon
    Chinsangaram, J
    Piccone, ME
    Grubman, MJ
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (12) : 9891 - 9898
  • [15] Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood
    Dalloul, A
    Oksenhendler, E
    Chosidow, O
    Ribaud, P
    Carcelain, G
    Louvet, S
    Massip, P
    Lebon, P
    Autran, B
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (04) : 329 - 336
  • [16] Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells
    Deng, Liang
    Dai, Peihong
    Ding, Wanhong
    Granstein, Richard D.
    Shuman, Stewart
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (20) : 9977 - 9987
  • [17] LEADER PROTEIN OF FOOT-AND-MOUTH-DISEASE VIRUS IS REQUIRED FOR CLEAVAGE OF THE P220 COMPONENT OF THE CAP-BINDING PROTEIN COMPLEX
    DEVANEY, MA
    VAKHARIA, VN
    LLOYD, RE
    EHRENFELD, E
    GRUBMAN, MJ
    [J]. JOURNAL OF VIROLOGY, 1988, 62 (11) : 4407 - 4409
  • [18] Modulation of immune system function by measles virus infection: Role of soluble factor and direct infection
    Fujinami, RS
    Sun, XM
    Howell, JM
    Jenkin, JC
    Burns, JB
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (12) : 9421 - 9427
  • [19] Blood monocytes consist of two principal subsets with distinct migratory properties
    Geissmann, F
    Jung, S
    Littman, DR
    [J]. IMMUNITY, 2003, 19 (01) : 71 - 82
  • [20] GRAY GM, 1975, J LIPID RES, V16, P441